Preeclampsia Prediction through Mid-Trimester Spot UACR

Published On: 04 Dec, 2023 11:41 AM | Updated On: 04 Dec, 2023 11:41 AM

Preeclampsia Prediction through Mid-Trimester Spot UACR

A recent study aimed to assess the utility of spot urinary albumin/creatinine ratio (UACR)––measured between 17 and 24 weeks of gestation––in predicting the subsequent development of preeclampsia in asymptomatic pregnant women. 

This was a prospective observational study conducted over one year that included 81 participants with singleton pregnancies and no associated complications. 

The results indicated a significant difference in mean UACR between women who developed preeclampsia and those with gestational diabetes mellitus. Further, a notable association between severe preeclampsia, preeclampsia, and gestational diabetes with UACR was elicited at a 22 cutoff. Among those with UACR > 22, the adverse outcomes included – intrauterine fetal demise 2.5%; low birth weight – 12.5%; and neonatal intensive care unit admissions 7.5%. 

It was concluded that mid-trimester spot UACR measurement effectively predicts preeclampsia before its clinical manifestations, with a UACR >= 171 mg/g demonstrating high sensitivity (83.3%) and specificity (98.6%).

Source: Latha AP, Haripriya V, Ramya Raj P. The Journal of Obstetrics and Gynecology of India. 2023 Oct 31:1-6.


user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks